Inhatarget Therapeutics
Rue Antoine De Saint-Exupery 2, 6041 Charleroi, Belgium
About the sponsor
Inhatarget Therapeutics focuses on oncology research centered on non-small cell lung cancer, with interest in advanced disease settings and treatments designed for patients with stage IV disease. Its clinical activity reflects a targeted effort in lung cancer care, particularly where new therapeutic options are needed alongside existing treatment approaches.
- Advanced NSCLC
- Stage IV lung cancer
- Inhaled therapies
- Add-on treatment strategies
The sponsor’s research activity is concentrated in respiratory oncology, with clinical interest in treatment concepts that address tumor involvement in the lungs through localized delivery approaches.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.